Shortlist by what you need
Start here if you know why you are leaving Viz.ai.
Want the closest match?
AidocMost similar to Viz.ai in what it does, its category and its price.
Visit (opens Aidoc in a new tab)Want the best rated?
AZmedRated 4.4 out of 5 in our review, against 4.4 for Viz.ai.
Visit (opens AZmed in a new tab)
At a glance
Green means better than Viz.ai, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
 Viz.aiBaseline | 4.4 | Not listed | No | Trusted by 2,000+ hospitals, cutting stroke transfer time by 44% in 2026 clinical data | |
| Aidoc | 4.4Same | Not listed | No | FDA-cleared triage AI hitting 97% sensitivity, deployed in nearly 2,000 hospitals | vs Viz.ai |
 CARPL.ai | 4.2−0.2 | Not listed | No | A vendor-neutral marketplace where radiologists test and deploy third-party AI algorithms against their own imaging data behind their own firewall. | vs Viz.ai |
 InHEART | 4.2−0.2 | Not listed | No | InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk. | vs Viz.ai |
 Proscia | 4.3−0.1 | Not listed | No | FDA-cleared digital pathology platform for primary diagnosis and biomarker research. | vs Viz.ai |
| AZmed | 4.4Same | Not listed | No | FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays. | vs Viz.ai |
 AISAP | 4.1−0.3 | Not listed | No | An FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time. | vs Viz.ai |
 Rayscape | 3.7−0.7 | Not listed | No | FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm. | vs Viz.ai |
 ThinkSono | 4.1−0.3 | Not listed | No | Guides a nurse through a DVT ultrasound in real time, cutting the pathway to 30 minutes. | vs Viz.ai |
The alternatives in detail
In order of how closely each one matches Viz.ai.
Aidoc
4.4Not listed
vs Viz.aiSame
FDA-cleared triage AI hitting 97% sensitivity, deployed in nearly 2,000 hospitals.
- AI triage scanning radiology images for time-sensitive critical findings
- FDA-cleared comprehensive triage covering 11 new plus 3 prior indications in one workflow
- 97% mean sensitivity and 98% mean specificity in the FDA pivotal study
Broad, single-workflow FDA clearance covers many conditions rather than just one
Enterprise pricing requires a sales conversation, no published self-serve rate
CARPL.ai
4.2Not listed
vs Viz.ai−0.2
A vendor-neutral marketplace where radiologists test and deploy third-party AI algorithms against their own imaging data behind their own firewall.
- Marketplace access to 275+ third-party radiology AI applications
- Universal AI viewer that standardizes output across vendors
- On-premises testing of algorithms against a hospital's own data before deployment
Vendor-neutral marketplace avoids locking a hospital into one AI vendor's roadmap
No published pricing, enterprise sales process required to get a quote
InHEART
4.2Not listed
vs Viz.ai−0.2
InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk.
- AI segmentation of CT and MRI scans into interactive 3D heart models
- 24-hour turnaround from scan submission to delivered model
- FDA 510(k)-cleared AI software for cardiac image segmentation
FDA 510(k) clearance gives the AI segmentation regulatory credibility beyond a research tool
No public pricing; adoption requires a hospital procurement and contracting process
Proscia
4.3Not listed
vs Viz.ai−0.1
FDA-cleared digital pathology platform for primary diagnosis and biomarker research.
- FDA-cleared for primary clinical diagnosis in AP-Dx
- Concentriq AP, AP-Dx and LS configurations
- Biomarker research and clinical trial workflows
FDA clearance for primary diagnosis, not just research viewing
No published pricing
AZmed
4.4Not listed
vs Viz.aiSame
FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays.
- FDA-cleared fracture, joint effusion, and dislocation detection (AZtrauma)
- FDA-cleared chest X-ray triage for nodules, pneumothorax, and pleural effusion (AZchest)
- Pediatric and adult population coverage
Multiple FDA clearances rather than a single narrow approval
No public pricing; only reachable through a sales demo
AISAP
4.1Not listed
vs Viz.ai−0.3
An FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time.
- Real-time AI interpretation of cardiac ultrasound images at the bedside
- FDA clearance in the CADx pathway for structural heart disease diagnosis via POCUS
- Structured, auto-generated reporting that cuts documentation time
FDA clearance gives it regulatory standing competitors without clearance lack
Pricing is entirely custom and undisclosed, making budget comparison hard upfront
Rayscape
3.7Not listed
vs Viz.ai−0.7
FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm.
- 148+ pathology detection on chest X-rays
- Pulmonary nodule detection, measurement, and tracking on lung CT
- Multiple FDA clearances and extensive clinical validation
Genuine regulatory clearance (FDA) rather than just a marketing claim
Pricing isn't public - requires direct institutional engagement
ThinkSono
4.1Not listed
vs Viz.ai−0.3
Guides a nurse through a DVT ultrasound in real time, cutting the pathway to 30 minutes.
- Real-time guidance for probe positioning and anatomy
- Proximal compression ultrasound for DVT
- Designed for non-ultrasound-trained clinicians
Compresses a day-long diagnostic pathway to about 30 minutes
Not FDA approved, so unavailable clinically in the United States
FAQ
Questions people ask
Is Viz.ai free?
Viz.ai does not list a free plan. Check its pricing page for current plans.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.